LISA W LEFKOVITS
Allopathic & Osteopathic Physicians|Internal Medicine MARIETTA, GA NPI 1962560128
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine GA Lilly USA, LLC All categories
General Payments — all program years on this page
$13,784.17
- Category: General Payments
- Program years: PY2018–2024
- Record count: 335
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,657.09 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,657.09 | 70 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $302.34 | 11 |
| UCB, Inc. | $234.37 | 8 |
| ABBVIE INC. | $219.82 | 10 |
| PFIZER INC. | $94.47 | 4 |
| Alexion Pharmaceuticals, Inc. | $91.91 | 4 |
| Genentech USA, Inc. | $84.67 | 4 |
| Amgen Inc. | $72.13 | 3 |
| Novo Nordisk AS | $64.16 | 4 |
| LivaNova USA, Inc. | $61.33 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.04 | 2 |
| Astellas Pharma US Inc | $54.72 | 2 |
| Janssen Biotech, Inc. | $46.61 | 2 |
| Lundbeck LLC | $44.29 | 2 |
| Exact Sciences Corporation | $38.73 | 2 |
| Xeris Pharmaceuticals, Inc. | $38.36 | 2 |
| Esperion Therapeutics, Inc. | $26.49 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.18 | 1 |
| SANOFI-AVENTIS U.S. LLC | $22.72 | 1 |
| ITI, Inc. | $20.65 | 1 |
| Merck Sharp & Dohme Corporation | $19.98 | 1 |
| IBSA Pharma Inc. | $19.80 | 1 |
| SCILEX PHARMACEUTICALS INC. | $18.32 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.